SomnoMed Limited
SOMNF · OTC
6/30/2025 | 6/30/2024 | 6/30/2023 | 6/30/2022 | |
|---|---|---|---|---|
| Market Cap | $135 | $34 | $75 | $102 |
| - Cash | $17 | $16 | $12 | $16 |
| + Debt | $8 | $7 | $24 | $12 |
| Enterprise Value | $126 | $25 | $87 | $99 |
| Revenue | $111 | $92 | $84 | $73 |
| % Growth | 21.6% | 9.6% | 15.2% | – |
| Gross Profit | $67 | $55 | $46 | $39 |
| % Margin | 59.9% | 60.2% | 54.7% | 53.9% |
| EBITDA | $2 | -$2 | -$3 | -$2 |
| % Margin | 1.4% | -2.5% | -3.7% | -2.7% |
| Net Income | -$3 | -$12 | -$8 | -$4 |
| % Margin | -3.1% | -13.4% | -9.6% | -6.1% |
| EPS Diluted | -0.016 | -0.1 | -0.097 | -0.054 |
| % Growth | 83.7% | -2.7% | -80.4% | – |
| Operating Cash Flow | $8 | -$6 | -$4 | $2 |
| Capital Expenditures | -$2 | -$1 | -$6 | -$9 |
| Free Cash Flow | $5 | -$8 | -$10 | -$7 |